Tenuifoliside B

Tenuifoliside B, a component isolated from Polygalae Radix, inhibits potassium cyanide (KCN) -induced hypoxia and scopolamine-induced memory impairment. Tenuifoliside B shows potential cognitive improvement and cerebral protective effects. Tenuifoliside B has potential to become an anti-AD lead compound[1][2].

Product Specifications

CAS Number

[139726-36-6]

UNSPSC

12352005

Hazard Statement

H315, H319

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/tenuifoliside-b.html

Purity

99.21

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

OC[C@@]1([C@H]([C@H](O)[C@@H](CO)O1)OC(/C=C/C2=CC(OC)=C(O)C(OC)=C2)=O)O[C@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)COC(C4=CC=C(O)C=C4)=O

Molecular Formula

C30H36O17

Molecular Weight

668.60

Precautions

H315, H319

References & Citations

[1]YongjiangWu, et al. Studies on the total synthesis of tenuifoliside B. Tetrahedron. 2017 Jun.|[2]Fumito KARAKIDA, et al. Cerebral Protective and Cognition-Improving Effects of Sinapic Acid in Rodents. Biol. Pharm. Bull. 30 (3) 514-519 (2007) .